TAC1 and irritable bowel syndrome: Dicetel also inhibits the contractile effect of digestive hormones and proinflammatory mediators such as cholecystokinin, gastrin, and substance P. These metabolites play a key part in the contraction of intestinal smooth muscles, and are linked to defecation-associated abdominal pain and discomfort in patients with IBS.